ZTZhen Tian

Zhen Tian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zhen Tian has a total of 120 co-authors. Here are the top co-authors by number of shared publications:

  • Jiang Li

    Department of Oral Pathology, Shanghai Ninth People's Hospital Shanghai Jiaotong University School of Medicine Shanghai China

    7 shared publications
  • Ting Gu

    Department of Oral Pathology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Shanghai Research Institute of Stomatology, Shanghai, China

    5 shared publications
  • Chunye Zhang

    Shanghai Key Laboratory of Stomatology, Department of Oral Pathology, National Clinical Research Center for Oral Diseases, National Center for Stomatology, Shanghai Research Institute of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai Ninth People's Hospital, College of Stomatology Shanghai Jiao Tong University Shanghai China

    4 shared publications
  • Lizhen Wang

    Shanghai Key Laboratory of Stomatology, Department of Oral Pathology, National Clinical Research Center for Oral Diseases, National Center for Stomatology, Shanghai Research Institute of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai Ninth People's Hospital, College of Stomatology Shanghai Jiao Tong University Shanghai China

    4 shared publications
  • Zhenyuan Han

    Department of Oral Pathology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    4 shared publications
  • Biao Yang

    Shanghai

    3 shared publications

Latest Publications

  • Open Access

    RUNX2 Rearrangement as a Recurrent Molecular Event and Diagnostic Marker in Salivary Gland Keratocystoma

    by Min Wang, Jia-Jun Qian, Nan-Nan Leng, Rui Yin, Yi-Ning He, Chun-Ye Zhang, Ting Gu, Jun-Qing Xue, Zhen Tian, Jiang Li, et al.

  • Expanding the Morphological, Immunohistochemical, and Molecular Spectrums of NUT Carcinoma at Rare Sites of Head and Neck Region

    by Jingjing Sun, Qianqian Chen, Limin Liu, Min Wang, Chunye Zhang, Ronghui Xia, Zhen Tian, Lizhen Wang, Jiang Li

    Objective: To expand the clinicopathological, immunohistochemical, and molecular spectrums of head and neck NUT carcinoma (HN‐NC) of rare sites and explore potential prognostic factors and treatments. Materials and Methods: HN‐NCs were confirmed by NUT immunostaining, fluorescence in situ hybridization and/or next generation sequencing. Immunohistochemistry for therapeutic markers and follow‐up were performed. Results: Fifteen HN‐NCs were collected. Most involved major salivary gland ( n = 7) and oral mucosa ( n = 5). Other sites included mandible ( n = 1), and maxilla ( n = 2). Nine out of 13 harbored BRD4::NUTM1 fusion while the others carrying rare ZNF532::NUTM1 , novel CCNT2::NUTM1 and WHSC1L1::NUTM1 fusion respectively. Microscopically, three unusual morphologies were observed, resembling differentiated papillary squamous cell carcinoma, myoepithelial carcinoma and small round cell malignancy, respectively. SOX2, PRAME, c‐MYC, EGFR showed positive staining in around half cases. During the average follow‐up time of 12.8 months, 3/13 patients suffered recurrence, 5 had distant metastasis and 5 died of disease. Integrating with published reports, Kaplan–Meier method revealed that tumor site was associated with overall survival ( p = 0.039), and fusion gene type was associated with disease‐free survival ( p = 0.039). Conclusions: HN‐NCs had dismal prognosis, especially those originating from oral mucosa. HN‐NC should be included in the differential diagnosis when encountering poorly differentiated/undifferentiated malignancies or carcinomas with squamous differentiation.

  • Differential Lymphocyte Infiltration Shapes Corticosteroid Efficacy in Oral Lichen Planus

    by Yiwen Deng, Yufeng Wang, Junjun Chen, Guanhuan Du, Hui Yao, Lei Pan, Ting Gu, Sven Eric Niklander, Zhen Tian, Guoyao Tang

    Background: Oral lichen planus (OLP) is a chronic, immune‐mediated disorder affecting 2%–4% of the population. Corticosteroids are commonly used for treatment, but responses vary, likely due to differences in lymphocyte profiles. This study evaluated the impact of CD20+ B cells and CD38+ plasma cells on corticosteroid efficacy in OLP patients. Patients and Methods: This retrospective study included 101 patients with symptomatic, diffuse, and severe OLP. Immunohistochemical staining identified CD3+ T cells, CD20+ B cells, and CD38+ plasma cells in tissue lesions. All patients received prednisone, and outcomes were assessed using Reticulation/Erosion/Ulceration (REU) and Visual Analog Scale (VAS) scores. Statistical analyses compared treatment responses based on lymphocyte profiles. Results: All patients showed CD3‐positive T cell infiltration. Patients in the CD20− group showed significantly greater reductions in REU and VAS scores than the CD20+ group, indicating that B cell infiltration may reduce corticosteroid efficacy. Conversely, CD38+ patients exhibited greater score reductions than CD38− patients, suggesting that plasma cells may enhance responsiveness to treatment. The CD38+/CD20− group exhibited the most favorable response; the CD38−/CD20+ group had the least. Conclusions: Infiltration by B cells and plasma cells influences corticosteroid response in OLP. B cells are associated with reduced efficacy, while plasma cells correlate with improved treatment outcomes.


  • Open Access

    Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw

    by Han-Jin Ruan, Heng Chen, Jin-Song Hou, Jin-Gang An, Yu-Xing Guo, Bing Liu, Lei Tian, Jian Pan, Jin-Song Li, Can-Hua Jiang, et al.


  • The genetic and immune features of salivary gland secretory carcinoma with high‐grade transformation

    by Yu Wang, Jingjing Sun, Bao Sun, Chunye Zhang, Zhen Tian, Lizhen Wang, Jiang Li

    Objectives: To compare the clinicopathological, molecular, and immune features of conventional and high‐grade transformation (HGT) secretory carcinoma (SC) in salivary glands.Materials and Methods: The clinicopathological data of 88 cases including 74 conventional SCs and 14 SCs with HGT were reviewed. Targeted next‐generation sequencing was performed in 11 SCs with HGT and 7 conventional SCs. The level of PD‐L1 and CD8+ TILs was determined by immunohistochemistry.Results: Compared with the conventional group, the rates of nodal metastasis, local recurrence, distant metastasis and mortality were significantly higher in the HGT cohort. Mutations of ARID1A/B, KMT2A, HOXD13, NRG1 and ETV6 genes were identified in HGT SCs. A recurrent E307G mutation in GATA6 gene was also observed in two cases. Two deceased HGT patients with distant metastasis harboured NOTCH3 mutations. ETV6‐RET translocation was prone to occur in the HGT SCs. Additionally, PD‐L1 expression was low, and CD8+ TILs were sparse in most HGT cases.Conclusion: Our findings reveal novel gene alterations involved in the progression of HGT in SCs. Most HGT SCs patients cannot benefit from PD‐L1 blocking and may be approached with a distinct treatment strategy including the lymph node dissection and application of molecular target drugs in precision oncology.


  • Open Access

    Head‐and‐neck dermatofibrosarcoma protuberans: Survival analysis and Clinically relevant immunohistochemical indicators

    by Zhenlin Dai, Youya He, Xu Zhang, Zhen Tian, Guopei Zhu, Zhenhu Ren, Lulu Ye, Zheqi Liu, Chunyue Ma, Wei Cao, et al.

    Background: Head and neck dermatofibrosarcoma protuberans (HNDFSP) is extremely rare and not entirely understood.Objective: To investigate the clinicopathological features of HNDFSP and identify the expression of its clinically relevant indicators, with the expectation of improving the existing treatment strategies.Methods: A long‐term follow‐up of patients with HNDFSP who received treatment between 2000 and 2021 at Shanghai Ninth People's Hospital was conducted. The clinical, histological, and immunohistochemical data of the patients were retrieved and analyzed. The endpoint of the study was the incidence of significant disease‐related clinical events (recurrences or metastasis).Results: A total of 49 patients with HNDFSP were included in the study, with males (92.7%) predominating than females (7.3%). Eighteen patients developed recurrent disease (36.8%) after surgery, and the median time of recurrence was 48 months (interquartile, 20–74 months). Metastasis occurred in two cases (4.1%). Two patients died during follow‐up, both with local recurrence, and one of them with intestinal metastasis. Post‐operation radiotherapy was administered to eight patients (16.3%) and the effect in local control was remarkable. Age, tumor size, and negative margins with sufficient safety width were the main independent factors affecting the disease‐free survival. Several potential targeted therapeutic indicators, including EZH2 (80.0%), EGFR (91.4%), PDGF (97.1%), PD‐L1 (77.1%), and VEGF (77.1%), were positively expressed in most tumor samples.Conclusion: HNDFSP is rare, significantly challenging to control locally, and has a worse prognosis with current treatment strategies. Wide local excision and long‐term follow‐up are needed. Radiotherapy could improve the prognosis of patients with HNDFSP.


  • Soluble E‐cadherin promotes invasiveness of neoplastic cells in salivary gland carcinoma ex pleomorphic adenoma

    by Wanling Chen, Sai Ye, Xiaoning Wang, Jiajun Qian, Liang Xia, Zhen Tian

    Background: Soluble E-cadherin (sEcad), a tumor suppressor gene, has pro-oncogenic effects by binding to human epithelial growth factor receptor 2 (HER-2). In our previous study, 1/3 of carcinoma ex pleomorphic adenoma (CXPA) cases had HER-2 amplification, which is associated with tumorigenesis and malignancy. This study examines the role of sEcad in HER-2 amplified CXPA.Methods: Immunohistochemistry was used to examine E-cadherin (Ecad) expression in HER-2-amplified CXPA samples (n = 35). Western blot and ELISA were used to detect sEcad in two samples with Ecad and HER-2 overexpression and CXPA cell line. Lentivirus-mediated transfection was performed to knock down sEcad in CXPA cells. The cell proliferation, wound healing, and transwell assays were used to compare sEcad-knockdown cells with cells pretreated with recombinant human sEcad (rhEcad/Fc). sEcad and HER-2 interaction was determined through co-immunoprecipitation. RNA-sequencing, differential expression analysis, GO and KEGG analysis were used to identify sEcad-related signaling pathways and their protein phosphorylation levels were verified by western blotting.Results: Ecad was overexpressed in 77.1% of HER-2-positive CXPA, and sEcad was found in the CXPA cell line and two samples. sEcad promoted CXPA migration and invasion in vitro without sEcad and HER-2 interaction. sEcad-related differentially expressed genes were enriched in the IL-17, cAMP, and MAPK signaling pathways. Furthermore, sEcad activated the phosphorylation of Akt and MAPK/ERK signaling pathways.Conclusions: Most HER-2+ CXPAs express Ecad. sEcad could affect the invasiveness and migration of in vitro CXPA cells without HER-2. sEcad may be a therapeutic biomarker for CXPA patients.


  • Expression and implications of cytology‐based miRNAs in oral premalignant and malignant lesions

    by Xi Yang, Linjun Shi, Guoyao Tang, Zhen Tian, Wei Liu

  • Adenoid cystic carcinoma in children and young adults: A clinicopathological study of 12 cases

    by Rong‐Hui Xia, Chun‐Ye Zhang, Li‐Zhen Wang, Yu‐Hua Hu, Jing‐Jing Sun, Zhen Tian, Jiang Li

    Objective: To investigate the clinicopathological characteristics, immunoprofile, and molecular alterations of adenoid cystic carcinoma (ACC) in children and young adults.Materials and methods: Twelve cases of ACC were included. MYB, MYBL1, Ki‐67, type IV Collagen, Laminin, and LAMB1 expression were detected by immunohistochemistry. MYB and MYBL1 rearrangements were detected by fluorescence in situ hybridization.Results: Among 12 patients, four were female and eight were male. Seven cases (58.3%) located in major salivary glands and eight cases (66.7%) were classified as Grade I. Ten tumors (83.3%) had collagenous and hyalinized stroma. MYB was positive in 83.3% cases, and the average Ki‐67 labeling index (LI) was 8.3%. LAMB1, type IV Collagen, and Laminin were positive in 91.7%, 66.7%, and 58.3% cases, respectively. Besides, three out of eight tumors had MYB rearrangement. Cases without MYB rearrangement were negative for MYBL1 expression and MYBL1 rearrangement. The average follow‐up time was 91.8 months. Four patients had recurrent diseases.Conclusions: ACC in children and young adults was seen more frequently in males and major salivary glands. Most cases had ECM and hyaline stroma. Grade III tumors, higher Ki‐67 LI, negative expression of type IV Collagen, and Laminin showed a tendency of higher recurrence rate.


  • Genetic heterogeneity and therapeutic target detection through microdissection in solid-type adenoid cystic carcinoma

    by Yu Wang, Bao Sun, Chunye Zhang, Ronghui Xia, Jingjing Sun, Ting Gu, Zhen Tian, Jiang Li